TSS
KBIO

Two Sigma Securities’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Two Sigma Securities’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,367
Closed -$21K – 333
2015
Q1 		$21K Buy
+5,367
New +$24.1K 0.02% 176

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Two Sigma Securities's KBIO Position: Q2 2015 in Review

Two Sigma Securities sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q2 2015, closing a stake of 5,367 shares — an estimated $21K sold.

Two Sigma Securities first reported a position in KBIO in Q1 2015 and held it in 1 quarter. The position peaked at $21K in Q1 2015. 19 funds tracked by Wall St. Rank hold KBIO as of Q2 2015.

  • Two Sigma Securities reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q2 2015 after selling out during the quarter.
  • Two Sigma Securities sold 5,367 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q2 2015, an estimated $21K.
  • Two Sigma Securities first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2015 and held it in 1 quarter.
  • Two Sigma Securities's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $21K in Q1 2015.
  • 19 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q2 2015.

Based on Two Sigma Securities's 13F filing for Q2 2015, filed 14 Aug 2015.